HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Andreas Machens Selected Research

Calcitonin (Calcitonin, Eel)

1/2015Surgical Treatment of Medullary Thyroid Cancer.
8/2014Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer.
4/2014Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective.
4/2013Benefit-risk balance of reoperation for persistent medullary thyroid cancer.
3/2013Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.
3/2013Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin.
1/2013Surgical management of the lateral neck compartment for metastatic thyroid cancer.
5/2012Biological relevance of medullary thyroid microcarcinoma.
1/2012Multiple endocrine neoplasia type 2: achievements and current challenges.
6/2010Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Andreas Machens Research Topics

Disease

31Neoplasm Metastasis (Metastasis)
01/2015 - 01/2002
20Neoplasms (Cancer)
01/2015 - 08/2003
14Thyroid Neoplasms (Thyroid Cancer)
03/2013 - 01/2002
9Pheochromocytoma
02/2013 - 07/2005
7Hyperplasia
09/2010 - 10/2003
5Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
04/2014 - 07/2005
4Goiter
03/2013 - 02/2003
4Multiple Endocrine Neoplasia Type 2a (MEN 2)
01/2012 - 07/2005
3Thyroid Diseases (Thyroid Disease)
01/2015 - 03/2013
2Genetic Predisposition to Disease (Genetic Predisposition)
07/2015 - 01/2012
2Renal Cell Carcinoma (Grawitz Tumor)
01/2015 - 01/2010
2Multiple Endocrine Neoplasia Type 2b (MEN 3)
04/2014 - 12/2008
2Nodular Goiter
03/2013 - 12/2011
2Primary Hyperparathyroidism
02/2013 - 01/2012
2Hypoparathyroidism
12/2011 - 02/2003
2Adenoma (Adenomas)
05/2007 - 03/2006
1Postoperative Pain
08/2014
1Lymphoma (Lymphomas)
03/2013
1Thyroiditis
03/2013
1Paralysis (Palsy)
11/2012
1Vocal Cord Paralysis
12/2011
1Endemic Goiter
12/2011
1Carcinoma (Carcinomatosis)
12/2008
1Hyperparathyroidism
08/2008
1Adrenocortical Carcinoma
09/2007
1Graves Disease (Basedow Disease)
02/2003

Drug/Important Bio-Agent (IBA)

20medullary Thyroid cancerIBA
07/2015 - 01/2004
15Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2015 - 04/2005
9Codon (Codons)IBA
01/2010 - 09/2003
6Factor IX (PTC)FDA LinkGeneric
12/2012 - 01/2002
6papillary Thyroid cancerIBA
12/2012 - 01/2004
5Carcinoembryonic AntigenIBA
03/2013 - 07/2006
3Pentagastrin (Peptavlon)FDA Link
03/2013 - 06/2008
3familial medullary Thyroid cancerIBA
03/2013 - 11/2004
2DNA (Deoxyribonucleic Acid)IBA
01/2015 - 01/2012
2IodineIBA
12/2011 - 12/2008
2follicular Thyroid cancerIBA
07/2010 - 06/2005
1procalcitoninIBA
08/2014
1CalciumIBA
03/2013
1Calcium Gluconate (CBG)IBA
03/2013
1Parathyroid Hormone (Parathormone)IBA
12/2011
1HormonesIBA
12/2011
1Mitotane (Lysodren)FDA Link
09/2007
1Cysteine (L-Cysteine)FDA Link
05/2007
1HLA-C Antigens (HLA-C)IBA
10/2006

Therapy/Procedure

11Thyroidectomy
01/2015 - 02/2003
10Lymph Node Excision (Lymph Node Dissection)
01/2015 - 01/2002
2Adrenalectomy
08/2006 - 07/2005
1Individualized Medicine
03/2013
1Dilatation and Curettage (D&C)
02/2013
1Tracheostomy
11/2012
1Parathyroidectomy
01/2009
1Radioimmunotherapy
07/2006
1Ligation
02/2003